Resources
Jump to Resources NavigationNews
Thursday 3rd July, 2008 Syntopix sign deal with Proctor and Gamble
Syntopix Group plc (AIM: SYN) the speciality pharmaceutical research and development company focused on dermatological diseases, is pleased to announce that it has entered into a joint development agreement with Procter & Gamble, the world’s largest consumer goods product company.
Read more of "Syntopix sign deal with Proctor and Gamble"...
News Archives
- Latest News
- March, 2011
- August, 2010
- July, 2010
- June, 2010
- May, 2010
- April, 2010
- March, 2010
- February, 2010
- January, 2010
- December, 2009
- November, 2009
- October, 2009
- September, 2009
- July, 2009
- June, 2009
- April, 2009
- March, 2009
- February, 2009
- January, 2009
- November, 2008
- October, 2008
- September, 2008
- August, 2008
- July, 2008
- June, 2008
- May, 2008
- April, 2008
- March, 2008
- January, 2008
- December, 2007
- November, 2007
- October, 2007
- August, 2007
- July, 2007
- June, 2007
- May, 2007
- April, 2007
- February, 2007
- December, 2006
- November, 2006
- October, 2006
- August, 2006
- June, 2006
- March, 2006
- January, 2006
- December, 2005
- November, 2005
- August, 2005
- July, 2005
- June, 2005
